This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Bar-Ilan University, Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.. Active years: 2026.
Company Filing History:
1 out of 244 
1 out of 911 
Years Active: 2026
Title: Shani Zeeli: Innovator in Indoline Derivatives
Introduction
Shani Zeeli is an accomplished inventor based in Ness Ziona, Israel. He has made significant contributions to the field of medicinal chemistry, particularly through his work on indoline derivatives. His innovative approach aims to address various diseases and disorders linked to oxidative stress and immune responses.
Latest Patents
Shani Zeeli holds a patent for "Indoline derivatives, compositions comprising them and uses thereof." This invention focuses on indoline derivatives and their salts, along with compositions that utilize these compounds for treating conditions associated with oxidative stress, immune responses, and the release of pro-inflammatory cytokines. He has 1 patent to his name, showcasing his dedication to advancing medical science.
Career Highlights
Throughout his career, Shani has worked with notable institutions, including Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. and Bar-Ilan University. His experience in these organizations has allowed him to collaborate with leading researchers and contribute to groundbreaking projects.
Collaborations
Shani has had the opportunity to work alongside esteemed colleagues, including Marta Weinstock-Rosin and Abraham Nudelman. These collaborations have enriched his research and expanded the impact of his inventions.
Conclusion
Shani Zeeli's work in the field of indoline derivatives exemplifies the innovative spirit of modern inventors. His contributions are paving the way for new treatments that could significantly improve patient outcomes.